Vericel Corporation (VCEL): a potential bargain?

Buy — the "82% crash" is 19-year-old history from a different company; the real business just posted record revenue, its first profitable quarter, raised guidance, and a new buyback.

🔥 HOT Fundamentals55/100

Down 83% from its all-time high of $252.80 — now $43.95

Why VCEL dropped

The all-time high dates to 2007 when this company was Aastrom Biosciences, a totally different pre-cell-therapy business — irrelevant to today. The only real recent move is a small ~9% pullback from a 30-day high, which happened right after Q2 2026 earnings that actually beat on revenue and EPS and raised full-year guidance; the dip looks like routine profit-taking on a "buy the rumor, sell the news" reaction, not a red flag.

Fwd P/E 52.0Op margin 0.6%Rev growth 22.5%Debt/equity 25.2%Analyst upside 37.8%

How this scored 55/100

✅ Passes all 4 hard checks — profitable, cash-generative, and financially survivable.

✅ Makes money Net profit margin 7.9%

✅ Generates cash Free cash flow $56M

✅ Not drowning in debt Debt/equity 25.2% (limit 200%)

✅ Can pay its bills Current ratio 5.0 (needs 1+)

Bar length shows how much each metric is worth — a 10-point metric is twice as wide as a 5-point one. Hover any row for what it means.

Profitability Does it actually make money? 4/25

Operating margin 0.6% 0/9

Net profit margin 7.9% 3/8

Return on equity 7.2% 1/8

Growth Is it getting bigger, or dying? 19/25

Revenue growth 22.5% 8/9

Earnings growth unknown 2/8

Expected profit change 80.0% 8/8

Value Is it cheap right now? 7/25

Forward P/E 52.0 0/10

PEG ratio unknown 2/8

Analyst target upside 37.8% 4/7

Balance sheet Will it survive? 25/25

Debt / equity 25.2% 10/10

Current ratio 5.0 8/8

Free cash flow $56M 7/7

🔒 Read the full AI analysis

Create a free account to unlock the bull case and the risks for VCEL — plus today's other picks.

Analysis generated by SmartStonks's AI from public fundamentals and news, first flagged 2026-08-11. Research only — not financial advice.